← Evidence map

ArticleBone reports2023

Eribulin mesylate induces bone mass loss by promoting osteoclastic bone resorption in mice.

Takahiro Ishizaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37305428